DNA & Clones

DNA was prepared from cell line WM3734. WM3734 is a tumorigenic metastatic primary melanoma cell line. This cell line was established from a brain metastatic site in a 24-year-old female. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM3734 cells produce xenograft tumors when injected into immunocompromised mice.

DNA was prepared from cell line WM3734. WM3734 is a tumorigenic metastatic primary melanoma cell line. This cell line was established from a brain metastatic site in a 24-year-old female. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. WM3734 cells produce xenograft tumors when injected into immunocompromised mice.

DNA was prepared from cell line WM3743. WM3743 is a primary post chemotherapy melanoma cell line that displays a mesenchymal morphology. This cell line expresses wild type N-RAS, c-KIT and CDK4 genes. WM3743 cells produce xenograft tumors when injected into immunocompromised mice.

DNA was prepared from cell line WM3743. WM3743 is a primary post chemotherapy melanoma cell line that displays a mesenchymal morphology. This cell line expresses wild type N-RAS, c-KIT and CDK4 genes. WM3743 cells produce xenograft tumors when injected into immunocompromised mice.

DNA was prepared from cell line WM3743. WM3743 is a primary post chemotherapy melanoma cell line that displays a mesenchymal morphology. This cell line expresses wild type N-RAS, c-KIT and CDK4 genes. WM3743 cells produce xenograft tumors when injected into immunocompromised mice.

DNA was prepared from cell line WM3749. WM3749 is a metastatic human melanoma cell line that displays a mesenchymal and dendritic morphology. This cell line was established from a metastatic tissue site in a 54-year-old female patient. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line also expresses PTEN loss of function including homozygous deletion, and is wild type for N-RAS, c-KIT, and CDK4. WM3749 cells produce xenograft tumors when injected into immunocompromised mice.

DNA was prepared from cell line WM3749. WM3749 is a metastatic human melanoma cell line that displays a mesenchymal and dendritic morphology. This cell line was established from a metastatic tissue site in a 54-year-old female patient. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line also expresses PTEN loss of function including homozygous deletion, and is wild type for N-RAS, c-KIT, and CDK4. WM3749 cells produce xenograft tumors when injected into immunocompromised mice.

DNA was prepared from cell line WM3749. WM3749 is a metastatic human melanoma cell line that displays a mesenchymal and dendritic morphology. This cell line was established from a metastatic tissue site in a 54-year-old female patient. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line also expresses PTEN loss of function including homozygous deletion, and is wild type for N-RAS, c-KIT, and CDK4. WM3749 cells produce xenograft tumors when injected into immunocompromised mice.

DNA was prepared from cell line WM3755. WM3755 is a metastatic human melanoma cell line that displays a mesenchymal morphology. This cell line features the specific V600E (Val600Glu) mutation at codon 600 in the BRAF gene. This mutation causes constitutively active kinase activity and activation of MEK and ERK signaling pathway. This cell line expresses wild type N-RAS, c-KIT, and CDK4 genes. WM3755 cells produce xenograft tumors when injected into immunocompromised mice.